The nature and management of acquired resistance to PD1-based therapy in melanoma.
Year: 2020
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Adriana Hepner, Judith M. Versluis, Camille Lea Gerard, Lauren Julia Brown, Roslyn Wallace, Prachi Bhave, Yanina Jansen, Oliver Klein, Allison Betof Warner, Joanna Mangana, Victoria Atkinson, Serigne Lo, Georgina V. Long, Douglas Buckner Johnson, Jennifer Leigh McQuade, Paolo Antonio Ascierto, Lisa Zimmer, Celeste Lebbe, Christian U. Blank, Alexander M. Menzies
Institutions: Melanoma Institute Australia, The Netherlands Cancer Institute, Centre Hospitalier Universitaire Vaudois, Westmead Hospital, Peter MacCallum Cancer Centre, Alfred Health, Universitair Ziekenhuis Brussel, Austin Health, Memorial Sloan Kettering Cancer Center, University Hospital Zurich, The University of Queensland, The University of Sydney, Royal North Shore Hospital, Vanderbilt University Medical Center, The University of Texas MD Anderson Cancer Center, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Essen University Hospital, University of Duisburg-Essen, Université Paris Cité, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Louis, HIPI - Immunologie humaine, physiopathologie et immunithérapie
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3032591746